Skip to main content
Premium Trial:

Request an Annual Quote

SummerBio Raises $7.3M, Implements SARS-CoV-2 Molecular Testing at Los Angeles Schools

NEW YORK ─ SummerBio on Wednesday announced it has raised $7.3 million in an equity financing round and is conducting testing for the University of California Los Angeles (UCLA) and the Los Angeles Unified School District that leverages its RT-PCR SARS-CoV-2 test.

Investors in the equity financing round included Intel Capital, Capricorn Investment Group, 8VC, Toyota AI Ventures, Joby Trust, Dayton Family Enterprises, and Sciarra Management Trust.

The firm said that its RT-PCR test is conducted in a CLIA-certified laboratory and administered by a healthcare professional using a nasal swab, leading to results within 24 hours of collection.

The test is based on an RT-PCR assay developed by a team at New York-based Columbia University. It leverages robotics and automated high-throughput liquid handling systems to reduce process inefficiencies and supply bottlenecks, SummerBio said.

The Menlo Park, California-based firm added that it plans to increase testing capacity for its COVID-19 laboratory to about 100,000 tests per day by the end of this year and offer testing at a cost of less than $20 per test.

The firm also said that Srini Ananth, investment director at Intel Capital, and Ajit Singh, partner at Artiman Ventures, joined SummerBio's board.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.